330729P
C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0)
Manufacturer: Sigma Aldrich
CAS Number: 2315262-18-9
Synonym(S): D-glucosyl-β-1,1′-N-pentadecanoyl-D-erythro-sphingosine-d7
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 330729P-1-MG | In Stock | ₹ 93,809.45 |
330729P - 1 MG
In Stock
Quantity
1
Base Price: ₹ 93,809.45
GST (18%): ₹ 16,885.701
Total Price: ₹ 1,10,695.151
Assay
99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (330729P-1MG)
manufacturer/tradename
Avanti Polar Lipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 2315262-18-9 | D-glucosyl-β-1,1'-N-pentadecanoyl-D-erythro-sphingosine-d7 | A2B Chem | ₹ 2,36,915.64 |
Related Products
Description
- General description: C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0) is a deuterated derivative of C15 Glucosyl(β) Ceramide. β-Glucosyl ceramide (β-GlcCer) is an intracellular metabolite. It is the first intermediate in the synthesis of glycosphigolipids. β-GlcCer is an endogenous ligand of Mincle.[1]
- Biochem/physiol Actions: β-Glucosyl ceramide (β-GlcCer) exhibits immunostimulatory activity. Accumulation of β-GlcCer is associated with Gaucher disease.[1]
- Packaging: 5 mL Amber Glass Screw Cap Vial
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
Assay: 99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (330729P-1MG)
manufacturer/tradename: Avanti Polar Lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
Assay:
99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (330729P-1MG)
manufacturer/tradename:
Avanti Polar Lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
Assay: >99% (TLC)
form: chloroform solution
packaging: package of 1 × 1 mg
manufacturer/tradename: Avanti Polar Lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: __
Assay:
>99% (TLC)
form:
chloroform solution
packaging:
package of 1 × 1 mg
manufacturer/tradename:
Avanti Polar Lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
__
Assay: __
form: methanol solution
packaging: pkg of 1 × 1 ea (330731-1EA)
manufacturer/tradename: Avanti Polar Lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: __
Assay:
__
form:
methanol solution
packaging:
pkg of 1 × 1 ea (330731-1EA)
manufacturer/tradename:
Avanti Polar Lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
__
Assay: __
form: methanol solution
packaging: ampule of 1 × 1 mL (330732-1EA)
manufacturer/tradename: Avanti Polar Lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: __
Assay:
__
form:
methanol solution
packaging:
ampule of 1 × 1 mL (330732-1EA)
manufacturer/tradename:
Avanti Polar Lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
__